Aspire Biopharma is a biotechnology company that develops nano technology drug formulation technology and medicinal products.
Aspire Biopharma has raised $22.5M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in April 2026.
Aspire Biopharma is headquartered in San Juan, Puerto Rico.
Aspire Biopharma is a biotechnology company that develops nano technology drug formulation technology and medicinal products.
Aspire Biopharma is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aspire Biopharma — Funding & Investors." VCBacked, April 20, 2026, https://www.vcbacked.co/company/aspire-biopharma. Accessed August 14, 2026.
VCBacked. (2026). Aspire Biopharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/aspire-biopharma
{{cite web |title=Aspire Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/aspire-biopharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated